Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 725.62

+3.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (2355)	3/19/2018 3:11:11 PM
From: Biotech Jim	Read Replies (3) of 3559

The market is yawning at REGN, or worse. The rallies get sold quickly. Just cannot get a break, but we need more positive things with Dupixent. Like in faster sales ramp and those additional indications moving forward quickly. Need more visibility on the pipeline. Perhaps AMGN could buy them out, the we could have an AMGN East and an AMGN West. That will never happen, just my sick joke. The big issue seems to be with the analysts like Michael Yee who has a hold on the stock. And sellers appearing as they do not want to lose any more of their huge gains?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next